Preoperative Bacteriuria Unconnected to Joint Infection
By LabMedica International staff writers Posted on 22 Aug 2017 |
Image: An arthrogram is used to help confirm periprosthetic joint infection (Photo courtesy of Dr. Robin Smithuis, MD).
Patients who undergo elective joint replacement are traditionally screened and treated for preoperative bacteriuria in order to prevent periprosthetic joint infection (PJI), but more recently, this practice has been questioned.
Periprosthetic joint infection (PJI) is one of the most challenging and frequent complications after lower-extremity joint (hip and knee) arthroplasty. However, there is no single accepted set of diagnostic criteria for PJI. Various definitions have been proposed; however, none have been widely adopted.
A team of scientists at Tampere University Hospital (Tampere, Finland) identified patients between September 2002 and December 2013 who had undergone a primary hip or knee replacement in a tertiary care hospital from the hospital database that included 23,171 joint replacements, 10, 200 hips, and 12,971 knees. Patients with subsequent PJI or superficial wound infection in a one-year follow-up period were identified based on prospective infection surveillance. The association between bacteriuria and PJI was examined using a multivariable logistic regression model.
The team found the incidence of PJI was 0.68%, a total of 158 patients. Preoperative bacteriuria was not associated with an increased risk of PJI either in the univariate 0.51% versus. 0.71%; Odds ratio (OR) = 0.72, (95% confidence interval (CI) 0.34 – 1.54) or in the multivariable the OR = 0.82, (95% CI 0.38 – 1.77) analysis. There were no cases where PJI was caused by a pathogen identified in the preoperative urine culture. Results were similar for superficial infections.
The authors concluded that there was no association between preoperative bacteriuria and postoperative surgical site infection. Based on these results, it seems that the preoperative screening and treatment of asymptomatic bacteriuria is not required. The study was published on July 28, 2017, in the journal Clinical Microbiology and Infection.
Related Links:
Tampere University Hospital
Periprosthetic joint infection (PJI) is one of the most challenging and frequent complications after lower-extremity joint (hip and knee) arthroplasty. However, there is no single accepted set of diagnostic criteria for PJI. Various definitions have been proposed; however, none have been widely adopted.
A team of scientists at Tampere University Hospital (Tampere, Finland) identified patients between September 2002 and December 2013 who had undergone a primary hip or knee replacement in a tertiary care hospital from the hospital database that included 23,171 joint replacements, 10, 200 hips, and 12,971 knees. Patients with subsequent PJI or superficial wound infection in a one-year follow-up period were identified based on prospective infection surveillance. The association between bacteriuria and PJI was examined using a multivariable logistic regression model.
The team found the incidence of PJI was 0.68%, a total of 158 patients. Preoperative bacteriuria was not associated with an increased risk of PJI either in the univariate 0.51% versus. 0.71%; Odds ratio (OR) = 0.72, (95% confidence interval (CI) 0.34 – 1.54) or in the multivariable the OR = 0.82, (95% CI 0.38 – 1.77) analysis. There were no cases where PJI was caused by a pathogen identified in the preoperative urine culture. Results were similar for superficial infections.
The authors concluded that there was no association between preoperative bacteriuria and postoperative surgical site infection. Based on these results, it seems that the preoperative screening and treatment of asymptomatic bacteriuria is not required. The study was published on July 28, 2017, in the journal Clinical Microbiology and Infection.
Related Links:
Tampere University Hospital
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia